Simple Summary With ever-increasing incidence, breast cancer is considered a most
diagnosed type of cancer among women worldwide. Breast cancer arises through malignant …

Purpose Chemotherapy has been the historical mainstay of treatment for patients with breast
cancer, with immunohistochemical markers and tumor characteristics driving treatment …

Purpose The proper validation of prognostic biomarkers is an important clinical issue in
breast cancer research. MicroRNAs (miRNAs) have emerged as a new class of promising …

Abstract tRNA-derived fragments offer a recently identified group of non-coding single-
stranded RNAs that are often as abundant as microRNAs in cancer cells and play important …

Breast cancer is a heterogeneous disease featuring distinct histological, molecular and
clinical phenotypes. Although traditional classification systems utilising clinicopathological …

The cellular heterogeneity of breast cancers still represents a major therapeutic challenge.
The latest genomic studies have classified breast cancers in distinct clusters to inform the …

Triple-negative breast cancer (TNBC) is a complex breast cancer subtype characterized by
the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal …

Breast cancer (BC) comprises a diverse spectrum of diseases featuring distinct presentation,
morphological, biological, and clinical phenotypes. BC behaviour and response to therapy …

Simple Summary Breast cancers are broadly classified into two subtypes: estrogen receptor-
positive and estrogen receptor-negative. Approximately 70% of breast cancers are estrogen …

Ovarian cancer is a complex disease marked by tumor heterogeneity, which contributes to
difficulties in diagnosis and treatment. New molecular targets and better molecular profiles …